Alex G. Howarth
CIK: 0001795798
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALT
Altimmune, Inc.
Discretionary Trading P&L
Holdings
About Howarth Alex G.
Howarth Alex G. (SEC CIK 0001795798) files insider reports with the SEC as Altimmune, Inc. (ALT).
Signal8 holds 2 ownership filings by Howarth Alex G. (1 Form 3, 1 Form 4), filed on Nov 4, 2026. Those filings report 1 transaction, the latest on Nov 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Howarth Alex G.'s filings is in MORRISTOWN, NJ.
Recent filings by Howarth Alex G.
- Nov 2, 2026: Grant or award of ALT derivative securities (Form 4, code A).
Other insiders filing for Altimmune, Inc. (ALT)
- Greenleaf Peter, Officer
- Arbet-Engels Christophe, Chief Medical Officer
- WEAVER GREGORY L, Chief Financial Officer
- MENZIUSO RICHARD THOMAS, Principal Accounting Officer
- Richardson Linda M, Chief Commercial Officer
- Durso Jerome Benedict, President and CEO